Thermoresponsive Polymer Nanoparticles From Epoxidized Oleyl Methacrylate: Synthesis, Characterization, and In Vitro Evaluation


Yucel Ayten N., Ay E. N., Nejati O., Torkay G., Bal-Ozturk A., Cayli G., ...Daha Fazla

JOURNAL OF APPLIED POLYMER SCIENCE, 2026 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2026
  • Doi Numarası: 10.1002/app.70432
  • Dergi Adı: JOURNAL OF APPLIED POLYMER SCIENCE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Chemical Abstracts Core, Chimica, Compendex, INSPEC
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Thermoresponsive polymer nanoparticles (PNPs) were developed from epoxidized oleyl methacrylate (EOM), an olive oil-derived renewable monomer bearing reactive epoxide groups that enable post- or pre-polymerization functionalization for future drug, imaging, or targeting molecule conjugation. Neutral and cationic PNPs were synthesized by UV-initiated free-radical polymerization of N-isopropylacrylamide (NIPAM), EOM, and 2-aminoethyl methacrylamide (2-AEMA) introduced to generate cationic surface chemistry. Dynamic light scattering showed hydrodynamic diameters of 188.2 nm (neutral; PDI 0.079) and 222.4 nm (cationic; PDI 0.200), while cationic PNPs exhibited a high positive zeta potential (+38.6 +/- 5.04 mV). Thermoresponsive behavior assessed by DLS revealed a sharp LCST-type transition for neutral PNPs at similar to 28 degrees C-32 degrees C, whereas cationic PNPs displayed a broader, shifted transition at similar to 35 degrees C-42 degrees C (similar to 38 degrees C), consistent with enhanced polymer-water interactions. In vitro, cationic PNPs reduced HCT116 colorectal cancer cell viability in a dose-dependent manner (IC50 = 0.26 +/- 0.02 mg/mL at 24 h) while showing no significant toxicity toward HUVECs. Scratch assays indicated inhibited HCT116 migration at 0.05-0.15 mg/mL. Hemocompatibility testing showed no detectable hemolysis up to 0.3 mg/mL and no effect on coagulation at <= 0.1 mg/mL, whereas >= 0.15 mg/mL inhibited clot formation. These results support EOM-based cationic thermoresponsive PNPs as sustainable, modular nanoplatforms for cancer-oriented biomedical applications.